Will patient-centric sampling become the norm for clinical trials after COVID-19?

James, Christopher A; Barfield, Matthew D; Maass, Katie F; Patel, Shefali R; Anderson, Melanie D

James, Christopher A; Barfield, Matthew D; Maass, Katie F; Patel, Shefali R; Anderson, Melanie D.

James CA; Amgen Research, Thousand Oaks, CA, USA. cajames@amgen.com.
Barfield MD; Roche, Basel, Switzerland.
Maass KF; Genentech, South San Francisco, CA, USA.
Patel SR; Janssen R&D, Spring House, PA, USA.
Anderson MD; Merck, Kenilworth, NJ, USA.

Nat Med ; 26(12): 1810, 2020 12.

Article in English | MEDLINE | ID: covidwho-940867

Subject(s)

COVID-19; Clinical Trials as Topic/standards; Diagnostic Techniques and Procedures/trends; Patient-Centered Care/methods; Specimen Handling; COVID-19/diagnosis; COVID-19/epidemiology; COVID-19/pathology; Clinical Trials as Topic/methods; Diagnostic Techniques and Procedures/standards; Humans; Molecular Diagnostic Techniques/methods; Molecular Diagnostic Techniques/standards; Molecular Diagnostic Techniques/trends; Pandemics; Patient-Centered Care/standards; Patient-Centered Care/trends; Reference Standards; Research Design; SARS-CoV-2; Specimen Handling/methods; Specimen Handling/standards; Specimen Handling/trends; Telemedicine/methods; Telemedicine/standards; Telemedicine/trends; United States/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Specimen Handling / Clinical Trials as Topic / Patient-Centered Care / Diagnostic Techniques and Procedures / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Humans Country/Region as subject: North America Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2020 Document Type: Article Affiliation country: S41591-020-01144-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google